Sava Infond’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$179K Hold
3,250
0.03% 176
2025
Q1
$230K Hold
3,250
0.04% 162
2024
Q4
$214K Buy
+3,250
New +$214K 0.04% 169